Market revenue in 2023 | USD 2.9 million |
Market revenue in 2030 | USD 4.1 million |
Growth rate | 5% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 48.28% in 2023. Horizon Databook has segmented the South Africa cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa held a substantial market share in 2017 among MEA countries. There is a huge prevalence of chronic diseases in this region. These diseases include HIV/AIDS, hypertension, asthma, and arthritis. Rising prevalence of these chronic diseases is anticipated to lead to an increase in the adoption of cannulas in the country. For instance, as per statistics published by the Statistics South Africa, the number of individuals suffering from HIV in the country increased from around 4.72 million in 2002 to 7.03 million in 2016.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account